Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OIG personnel shake-up

This article was originally published in The Gray Sheet

Executive Summary

HHS Inspector General Janet Rehnquist decides to resign effective June 1. The move follows the receipt by Finance Committee Ranking Democrat Max Baucus (D-Mont.) and Senate Finance Chairman Charles Grassley (R-Iowa) of a draft GAO investigation on recent personnel changes at OIG and how they may compromise OIG's ability to police fraud. Rehnquist's departure is appropriate "under the circumstances," according to Baucus who was preparing to ask for Rehnquist's resignation before she announced her intention to step down on March 6, according to a Senate aide. A draft of the report will be available by the end of March...

You may also be interested in...



DME Suppliers Spotlighted In OIG Joint Venture Kickbacks Advisory

The Bush Administration is accelerating efforts to block kickbacks arising from contractual joint ventures in the health care system, highlighting durable medical device manufacturers and dialysis supply centers as common violators

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel